Ken Fisher Fisher Asset Management
AUM
$252B
1-Year Est. Return
19.67%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
1 Year Est. Return
+19.67%
AUM
$252B
AUM Growth
+$20.9B
(+9%)
Holding
1,093
Top Buys
| 1 | +$696M | |
| 2 | +$424M | |
| 3 | +$402M | |
| 4 |
SAP
SAP
|
+$354M |
| 5 |
Spotify
SPOT
|
+$353M |
Top Sells
| 1 | +$1.91B | |
| 2 | +$1.3B | |
| 3 | +$1.04B | |
| 4 |
Eli Lilly
LLY
|
+$886M |
| 5 |
JPMorgan Chase
JPM
|
+$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanguard Short-Term Corporate Bond ETF
VCSH
$39.5B
| $28.4M | 0.01% |
357,860
-53,148
|
|
||
277
First American
FAF
$6.49B
| $28.2M | 0.01% |
458,901
-30,930
|
|
||
278
Taylor Morrison
TMHC
$5.9B
| $28M | 0.01% |
456,676
-789,299
|
|
||
279
Patterson-UTI
PTEN
$2.55B
| $27.9M | 0.01% |
4,709,615
-592,527
|
|
||
280
Helmerich & Payne
HP
$2.55B
| $26.7M | 0.01% |
1,760,541
-91,008
|
|
||
281
Ferrovial SE
FER
$46.2B
| $26.6M | 0.01% |
496,437
+116,229
|
|
||
282
Murphy Oil
MUR
$4.13B
| $26.6M | 0.01% |
1,180,428
-24,297
|
|
||
283
Baker Hughes
BKR
$46.6B
| $26.2M | 0.01% |
683,408
-74,296
|
|
||
284
Tetra Tech
TTEK
$8.88B
| $26.1M | 0.01% |
725,624
-139,413
|
|
||
285
Texas Capital Bancshares
TCBI
$3.9B
| $25.9M | 0.01% |
326,286
-13,430
|
|
||
286
American Eagle Outfitters
AEO
$2.81B
| $25.7M | 0.01% |
2,676,307
-74,998
|
|
||
287
UFP Industries
UFPI
$5.38B
| $25.5M | 0.01% |
256,710
-87,141
|
|
||
288
APA Corp
APA
$8.53B
| $25.2M | 0.01% |
1,377,656
-70,594
|
|
||
289
Boot Barn
BOOT
$6.02B
| $25.2M | 0.01% |
165,494
+162,106
|
|
||
290
DexCom
DXCM
$27.6B
| $25M | 0.01% |
286,620
-113,251
|
|
||
291
BioCryst Pharmaceuticals
BCRX
$1.52B
| $24.9M | 0.01% |
2,782,489
-269,648
|
|
||
292
Edwards Lifesciences
EW
$44.7B
| $24.7M | 0.01% |
316,392
-9,784,074
|
|
||
293
Banner Corp
BANR
$2.17B
| $24.5M | 0.01% |
382,478
-14,141
|
|
||
294
Prestige Consumer Healthcare
PBH
$3.06B
| $24.4M | 0.01% |
305,626
-22,434
|
|
||
295
Cytokinetics
CYTK
$6.92B
| $24.2M | 0.01% |
733,680
-59,778
|
|
||
296
Medtronic
MDT
$120B
| $23.9M | 0.01% |
274,066
-638,446
|
|
||
297
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.27B
| $23.7M | 0.01% |
1,018,357
+31,308
|
|
||
298
Levi Strauss
LEVI
$8.12B
| $23.5M | 0.01% |
1,272,867
+697,214
|
|
||
299
Independence Realty Trust
IRT
$3.8B
| $23.2M | 0.01% |
1,313,926
-569,745
|
|
||
300
Resideo Technologies
REZI
$6.62B
| $23.1M | 0.01% |
1,046,322
+392,773
|
|